For the quarter ending 2026-03-31, ADIL has $5,227,321 in assets. $1,510,071 in debts.
| Balance Sheets | 2026-03-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|
| Cash and cash equivalents | 4,584,100 | 4,606,289 | 5,914,980 | |
| Prepaid expenses and other current assets | 218,848 | 407,543 | 163,647 | |
| Total current assets | 4,802,948 | 5,013,832 | 6,078,627 | |
| Intangible assets, net | 2,643 | 2,925 | 3,066 | |
| Equity method investment | 421,730 | 643,090 | 720,010 | |
| Total assets | 5,227,321 | 5,659,847 | 6,801,703 | |
| Accounts payable, related party-Related Party | - | - | 0 | |
| Accounts payable | 573,567 | 556,284 | 671,118 | |
| Accrued expenses | 936,504 | 598,472 | 539,909 | |
| Total current liabilities | 1,510,071 | 1,154,756 | 1,211,027 | |
| Total liabilities | 1,510,071 | 1,154,756 | 1,211,027 | |
| Common stock, 100,000,000 shares authorized with a par value of 0.001 per share, 1,509,200 and 1,111,010 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 1,509 | 23,836 | 21,535 | |
| Additional paid in capital | 95,710,627 | 92,457,586 | 91,751,821 | |
| Accumulated deficit | -91,994,886 | -87,976,331 | -86,182,680 | |
| Total stockholders equity | 3,717,250 | 4,505,091 | 5,590,676 | |
| Total liabilities and stockholders equity | 5,227,321 | 5,659,847 | 6,801,703 | |
ADIAL PHARMACEUTICALS, INC. (ADIL)
ADIAL PHARMACEUTICALS, INC. (ADIL)